Potent homophthalimide-type inhibitors of B16F10/L5 mouse melanoma cell invasion

Citation
H. Kagechika et al., Potent homophthalimide-type inhibitors of B16F10/L5 mouse melanoma cell invasion, BIOL PHAR B, 22(9), 1999, pp. 1010-1012
Citations number
18
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOLOGICAL & PHARMACEUTICAL BULLETIN
ISSN journal
09186158 → ACNP
Volume
22
Issue
9
Year of publication
1999
Pages
1010 - 1012
Database
ISI
SICI code
0918-6158(199909)22:9<1010:PHIOBM>2.0.ZU;2-Y
Abstract
Recently, we developed a series of novel and patent amino-peptidase inhibit ors with a homophthalimide skeleton. Among them, N-(2,6-diethylphenyl)homop hthalimide (PIQ-22) possesses a specific aminopeptidase-inhibiting activity more potent than that of bestatin or actinonin, as assayed In terms of hyd rolysis of L-alanine 4-methylcoumaryl-7-amide (Ala-AMC) by human acute lymp hoblastic leukemia MOLT-4 cells. We show here that PIQ-22 and its 2,6-dimet hylphenyl derivative (PIQ-11) are more potent inhibitors of tumor cell inva sion than bestatin and actinonin in a Matrigel assay using mouse melanoma B 16F10/L5 cells.